Abstract
Acquisition of new stem cell fates relies on the dissolution of the prior regulatory network sustaining the existing cell fates. Currently, extensive insights have been revealed for the totipotency regulatory network around the zygotic genome activation (ZGA) period. However, how the dissolution of the totipotency network is triggered to ensure the timely embryonic development following ZGA is largely unknown. In this study, we identify the unexpected role of a highly expressed 2-cell (2C) embryo specific transcription factor, ZFP352, in facilitating the dissolution of the totipotency network. We find that ZFP352 has selective binding towards two different retrotransposon sub-families. ZFP352 coordinates with DUX to bind the 2C specific MT2_Mm sub-family. On the other hand, without DUX, ZFP352 switches affinity to bind extensively onto SINE_B1/Alu sub-family. This leads to the activation of later developmental programs like ubiquitination pathways, to facilitate the dissolution of the 2C state. Correspondingly, depleting ZFP352 in mouse embryos delays the 2C to morula transition process. Thus, through a shift of binding from MT2_Mm to SINE_B1/Alu, ZFP352 can trigger spontaneous dissolution of the totipotency network. Our study highlights the importance of different retrotransposons sub-families in facilitating the timely and programmed cell fates transition during early embryogenesis.
Introduction
In the earliest stages of mammalian development, embryos enter a state of totipotency, where cells possess the potential to differentiate into any embryonic or extra-embryonic lineage. While the activation of this state—driven largely by the master regulator DUX—is well-characterized, the mechanisms governing its dissolution are less understood. Timely exit from totipotency is essential; prolonged maintenance of this state can lead to developmental arrest. This study investigates the molecular "exit strategy" required to dismantle the totipotency network and progress toward later embryonic stages.
Methods and Data
The researchers employed a multi-omics approach using mouse embryonic stem cells (mESCs) and live mouse embryos. Key methodologies included:
- Genomic Mapping: ChIP-seq and ATAC-seq were used to identify ZFP352 and DUX binding sites and chromatin accessibility.
- Single-Cell Analysis: scRNA-seq tracked transcriptomic shifts as cells transitioned through "2-cell-like" (2CLC) states.
- Functional Perturbation: siRNA knockdown and overexpression (OE) assays in embryos and mESCs assessed the developmental impact of ZFP352.
- Biochemical Assays: Co-immunoprecipitation and ubiquitination assays identified the physical interactions and degradation targets of the ZFP352-induced machinery.
The study integrated original data with public datasets for 2CLC entry/exit and mouse embryo development, utilizing the RepeatMasker library to specifically analyze the role of retrotransposons.
Results
The Totipotency Landscape and Retrotransposon Dynamics
Single-cell transcriptomic mapping identified distinct clusters representing mESCs, 2CLCs, and intermediate states. A defining feature of the totipotent 2CLC state is the high expression of the MT2_Mm retrotransposon family. Initially, ZFP352 acts as a partner to DUX, binding to MT2_Mm elements to support the 2C-specific network.
ZFP352 as a Molecular Switch
As DUX levels fluctuate, ZFP352 undergoes a critical "binding shift." In the absence of DUX, ZFP352 pivots its affinity toward SINE_B1/Alu retrotransposons. This shift is mediated by a shared 9-base-pair motif (CCTTTAATC) present in both retrotransposon families. Binding to SINE_B1 elements allows ZFP352 to activate later developmental programs, specifically the ubiquitination pathway involving the E3 ligase TRIM43A.
Facilitating the Exit from Totipotency
Functional assays demonstrated that ZFP352 is essential for the timely dissolution of the totipotency network. Overexpressing ZFP352 in a Dux-inducible system significantly reduced the proportion of cells remaining in the 2C-like state. Mechanistically, ZFP352-induced TRIM43A targets DUX and other totipotency factors (like ZSCAN4) for proteasomal degradation, effectively dismantling the network from within.
Knockdown of Zfp352 in mouse embryos resulted in a significant delay in the transition to the morula stage, with cells becoming transcriptomically "stuck" in a partial totipotent state.
Discussion
This study identifies ZFP352 as a critical molecular timer that triggers the spontaneous dissolution of the totipotency network once a concentration threshold is reached. By shifting its binding between different retrotransposon sub-families, ZFP352 coordinates the transition from genome activation to the activation of the "cleanup crew" (ubiquitination machinery) that degrades earlier master regulators. While ZFP352 is a primary driver, other processes like RNA splicing likely contribute to this transition. Future work is required to determine if a similar retrotransposon-based switch governs the exit from totipotency in human development.
Summary updated